In addition, others have reported emergence of KRAS mutations in liver metastases not detectable in the colonic biopsy, highlighting the role of intra-tumour heterogeneity as a major contributing factor for intrinsic and/or acquired resistance [19]. Here, KRAS is linked to neoplasm.